Extended distribution deal for Rhinomed

Company News

Respiratory technology company Rhinomed (ASX:RNO) has announced it has been advised by leading Australian pharmacy wholesale distributor, Sigma Healthcare, its Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.

The new deal adds to Rhinomed’s existing Sigma relationship under which Discount Drug Stores stock Mute.

The company said Sigma has also confirmed the Mute product suite is now available for order by over 4,000 pharmacies in its distribution network.

The core ranging means all four Mute products (trial pack, small, medium and large) will be available in Amcal and Guardian stores Australia wide. An initial order is expected shortly. The expanded access by Sigma Healthcare allows every pharmacy within the Sigma network to range Mute.

"This latest deal, combined with the other recent announcements means Mute is now ranged in a significant number of Australian pharmacies. The company believes this is a giant step in ensuring that Mute can become Australia's premier, front line solution for snoring and nasal congestion," said Rhinomed in as statement.

Mute is an over-the-counter product that supports nasal breathing, enabling snorers or those with nasal obstruction and congestion to breathe more easily through their nose and help keep their mouth closed during sleep. Mute is designed to fit the natural anatomy of the nose and is individually adjustable on both sides so you can control the level of dilation and airflow.